Accelerating discovery of liver disease mechanisms

Researchers at a university are using an AI system called Co-Scientist to help understand a common liver disease involving inflammation and metabolism problems. The disease is difficult to treat because it involves multiple interconnected biological processes, which means drugs targeting single mechanisms are ineffective, pushing researchers to explore combination therapies. Co-Scientist analyzed scientific literature to identify overlooked connections and suggest candidate drug combinations worth testing. In one case, the system generated a hypothesis about a specific molecular mechanism linking inflammation and metabolism in the disease, which was later experimentally verified and could lead to new targeted treatments.